Pharmafile Logo

Medscape Oncology Launches Inaugural Medscape Fellows Program at ASCO 2024

- PMLiVE

Medscape Oncology is excited to announce the launch of the first-ever Medscape Fellows Program at the 2024 ASCO meeting in Chicago, Illinois. This groundbreaking program aims to nurture young oncology talent and advance outcomes through education.

“Today’s fellows represent the future of oncology. Our Medscape Oncology Fellows are poised to become leaders in cancer care, and we wanted to bring them together at oncology’s biggest event in the United States to show them the impact they can make. We’re looking forward to a weekend full of events and programs for them,” said Natasha McGrath, Executive Director, Medscape Education.

The Medscape Fellows Program will kick off with a welcome reception and feature a series of events throughout the weekend designed to inspire, educate, and connect fellows with leading experts in the field. By engaging in workshops, networking opportunities, symposia, and focus group sessions, fellows will gain valuable insights and skills to advance their careers and improve patient outcomes.

Medscape will also use insights from this program to help build new tools and programs designed to engage and elevate both fellows and young faculty. By placing education at the forefront, Medscape aims to advance clinical practice and improve patient outcomes.

For more information on the Medscape Fellows Program, please contact Natasha McGrath at NMcGrath@Medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Shifting the Paradigm: A New Era for Parkinson’s Care

In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.

World Orphan Drug Congress 2025 in Amsterdam

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Medscape Education: Pioneering Pathways at ESMO 2025

Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.

Game On: Medscape Education Golfs for a Cause

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...

Innovation in Action at AAFP FMX 2025

This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...

Shifting the Paradigm: A New Era for Parkinson’s Care

In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.

Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education

UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities

Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...

Virtual Practice, Real Results: The Power of Virtual Patient Simulation

Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language models for clinical answers1, the real differentiator isn’t just...

A New Destination for Oncology Education

Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce...